Malini P L, Strocchi E, Ambrosioni E, Magnani B
Int J Clin Pharmacol Res. 1983;3(1):35-9.
In a double-blind, cross-over, placebo-controlled study the efficacy of a new antihypertensive agent, guanfacine, was compared that of with methyldopa. Guanfacine was more effective in controlling blood pressure than methyldopa, but it induced a slightly higher incidence of side-effects.
在一项双盲、交叉、安慰剂对照研究中,对一种新型抗高血压药物胍法辛与甲基多巴的疗效进行了比较。胍法辛在控制血压方面比甲基多巴更有效,但它引起的副作用发生率略高。